(Australia-NewsWire.Com, June 14, 2018 ) A qPCR, otherwise called real-time polymerase chain reaction, is a lab strategy for molecular biology-dependent on the polymerase chain reaction. QPCR screens the amplification of the particular DNA segment amid the polymerase chain reaction, that is, in real time, as opposed to the ordinary polymerase chain reaction that screen toward the finish of the procedure. QPCR can be utilized as a part of two distinct varieties, in particular, semi-quantitative real-time polymerase chain reaction and quantitative real-time polymerase chain reaction. Attributable to the expanding interest for the qPCR reagents, the worldwide market is relied upon to develop sooner rather than later.
Expanding number of research and forensic laboratories and CROs is a key factor in charge of market development. Laboratories and CROs utilize qPCR and dPCR techniques for gene-based, protein-based, and different other research applications inferable from its high exactness and affectability. Expanding inclination of PCR techniques in pre-birth genetic testing and its related favorable circumstances in pre-birth genetic testing, for example, absence of requirement for reference guidelines, low process durations, and reproducible outcomes are a portion of the drivers anticipated that would move development.
Global qPCR Reagents Market is geographically segmented in regions of Asia Pacific, Latin America, North America, Europe and Middle East and Africa. Asia Pacific Market is geographically segmented into countries of India, China, Japan, South Korea and Australia. The Asia Pacific qPCR Reagents was worth USD 0.22 billion in 2016 and estimated to be growing at a CAGR of 9.21%, to reach USD 0.35 billion by 2021.
There are number of multinational companies operating in the field of qPCR reagents market. The major market players in the Asia Pacific qPCR Reagents market are Thermo Fisher Scientific, Bio-Rad Laboratories, Qiagen N.V., F. Hoffmann-La Roche, Agilent Technologies Inc., Takara Bio, Affymetrix Inc., Promega Corporation, Sigma-Aldrich Corporation, and Quanta Biosciences.